Somatic genomic changes in single Alzheimer's disease neurons

© 2022. The Author(s), under exclusive licence to Springer Nature Limited..

Dementia in Alzheimer's disease progresses alongside neurodegeneration1-4, but the specific events that cause neuronal dysfunction and death remain poorly understood. During normal ageing, neurons progressively accumulate somatic mutations5 at rates similar to those of dividing cells6,7 which suggests that genetic factors, environmental exposures or disease states might influence this accumulation5. Here we analysed single-cell whole-genome sequencing data from 319 neurons from the prefrontal cortex and hippocampus of individuals with Alzheimer's disease and neurotypical control individuals. We found that somatic DNA alterations increase in individuals with Alzheimer's disease, with distinct molecular patterns. Normal neurons accumulate mutations primarily in an age-related pattern (signature A), which closely resembles 'clock-like' mutational signatures that have been previously described in healthy and cancerous cells6-10. In neurons affected by Alzheimer's disease, additional DNA alterations are driven by distinct processes (signature C) that highlight C>A and other specific nucleotide changes. These changes potentially implicate nucleotide oxidation4,11, which we show is increased in Alzheimer's-disease-affected neurons in situ. Expressed genes exhibit signature-specific damage, and mutations show a transcriptional strand bias, which suggests that transcription-coupled nucleotide excision repair has a role in the generation of mutations. The alterations in Alzheimer's disease affect coding exons and are predicted to create dysfunctional genetic knockout cells and proteostatic stress. Our results suggest that known pathogenic mechanisms in Alzheimer's disease may lead to genomic damage to neurons that can progressively impair function. The aberrant accumulation of DNA alterations in neurodegeneration provides insight into the cascade of molecular and cellular events that occurs in the development of Alzheimer's disease.

Medienart:

E-Artikel

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Zur Gesamtaufnahme - volume:604

Enthalten in:

Nature - 604(2022), 7907 vom: 19. Apr., Seite 714-722

Sprache:

Englisch

Beteiligte Personen:

Miller, Michael B [VerfasserIn]
Huang, August Yue [VerfasserIn]
Kim, Junho [VerfasserIn]
Zhou, Zinan [VerfasserIn]
Kirkham, Samantha L [VerfasserIn]
Maury, Eduardo A [VerfasserIn]
Ziegenfuss, Jennifer S [VerfasserIn]
Reed, Hannah C [VerfasserIn]
Neil, Jennifer E [VerfasserIn]
Rento, Lariza [VerfasserIn]
Ryu, Steven C [VerfasserIn]
Ma, Chanthia C [VerfasserIn]
Luquette, Lovelace J [VerfasserIn]
Ames, Heather M [VerfasserIn]
Oakley, Derek H [VerfasserIn]
Frosch, Matthew P [VerfasserIn]
Hyman, Bradley T [VerfasserIn]
Lodato, Michael A [VerfasserIn]
Lee, Eunjung Alice [VerfasserIn]
Walsh, Christopher A [VerfasserIn]

Links:

Volltext

Themen:

9007-49-2
DNA
Journal Article
Nucleotides

Anmerkungen:

Date Completed 29.04.2022

Date Revised 14.02.2024

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1038/s41586-022-04640-1

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM339735414